Positive results of Phase III study of adapalene/benzoyl peroxide/clindamycin gel (IDP-126) in acne vulgaris announced
The randomised, double-blind 12-week study compared IDP-126 to vehicle gel, applied once daily for 12 weeks, in patients aged ≥9 years with acne vulgaris. All three co-primary endpoints were achieved, with treatment success in 50.5% versus 20.5% with the vehicle gel.
Source:
Biospace Inc.
SPS commentary:
The randomised, double-blind 12-week study compared IDP-126 to vehicle gel, applied once daily for 12 weeks, in patients aged ≥9 years with acne vulgaris. All three co-primary endpoints were achieved, with treatment success in 50.5% versus 20.5% with the vehicle gel.